Effects of calcium-removal and sodium-potassium adenosine triphosphatase inhibition on the release of epinephrine from the extraneuronal site.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D004789:Enzyme Activation; D004837:Epinephrine / Q000378:metabolism*; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008297:Male; D009474:Neurons; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D014649:Vas Deferens / Q000187:drug effects / Q000378:metabolism*
D004533:Egtazic Acid; D010042:Ouabain; D012964:Sodium; D000251:Adenosine Triphosphatases; D003000:Clonidine; D011188:Potassium; D002118:Calcium; D004837:Epinephrine